Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:609-613
doi: 10.1161/hy0202.103293
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauterbach, B.
Right arrow Articles by Schunck, W.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauterbach, B.
Right arrow Articles by Schunck, W.-H.
Related Collections
Right arrow Ion channels/membrane transport
Right arrow Other Vascular biology

(Hypertension. 2002;39:609.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators

Birgit Lauterbach; Eduardo Barbosa-Sicard; Mong-Heng Wang; Horst Honeck; Eva Kärgel; Jürgen Theuer; Michal L. Schwartzman; Hermann Haller; Friedrich C. Luft; Maik Gollasch; Wolf-Hagen Schunck

From the Max Delbrück Center for Molecular Medicine and Franz Volhard Clinic HELIOS Kliniken-Berlin, Medical Faculty of the Charité, Humboldt University of Berlin (B.L., E. B.-S., H.H., E.K., J.T., F.C.L., M.G., W.-H.S.); the New York Medical College (M.H.-W., M.L.S.), Valhalla, NY; and the Department of Internal Medicine-Nephrology, Hannover Medical School (H.H.), Hannover, Germany

Correspondence to Wolf-Hagen Schunck, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str 10, 13092 Berlin, Germany. E-mail schunck{at}mdc-berlin.de

P450-dependent arachidonic acid (AA) metabolites regulate arterial tone by modulating calcium-activated (BK) potassium channels in vascular smooth muscle cells (VSMC). Because eicosapentaenoic acid (EPA) has been reported to improve vascular function, we tested the hypothesis that P450-dependent epoxygenation of EPA produces alternative vasoactive compounds. We synthesized the 5 regioisomeric epoxyeicosattrienoic acids (EETeTr) and examined them for effects on K+ currents in rat cerebral artery VSMCs with the patch-clamp technique. 11(R),12(S)-epoxyeicosatrienoic acid (50 nmol/L) was used for comparison and stimulated K+ currents 6-fold at +60 mV. However, 17(R),18(S)-EETeTr elicited a more than 14-fold increase. 17(S),18(R)-EET and the remaining four regioisomers were inactive. The effect of 17(R),18(S)-EETeTr was blocked by tetraethylammonium but not by 4-aminopyridine. VSMCs expressed P450s 4A1 and 4A3. Recombinant P450 4A1 hydroxylated EPA at C-19 and C-20 and epoxygenated the 17,18-double bond, yielding the R, S- and S, R-enantiomers in a ratio of 64:36. We conclude that 17(R),18(S)-EETeTr represents a novel, potent activator of BK potassium channels. Furthermore, this metabolite can be directly produced in VSMCs. We suggest that 17(R),18(S)-EETeTr may function as an important hyperpolarizing factor, particularly with EPA-rich diets.


Key Words: vascular smooth muscle cells • endothelium-derived factors • potassium channels • cytochrome P450




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. A. Spector
Arachidonic acid cytochrome P450 epoxygenase pathway
J. Lipid Res., April 1, 2009; 50(Supplement): S52 - S56.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Morin, M. Sirois, V. Echave, E. Rizcallah, and E. Rousseau
Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung
Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L130 - L139.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. L. Hall, K. A. Sanders, T. A. B. Sanders, and P. J. Chowienczyk
A High-Fat Meal Enriched with Eicosapentaenoic Acid Reduces Postprandial Arterial Stiffness Measured by Digital Volume Pulse Analysis in Healthy Men
J. Nutr., February 1, 2008; 138(2): 287 - 291.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. C. Hercule, B. Salanova, K. Essin, H. Honeck, J. R. Falck, M. Sausbier, P. Ruth, W.-H. Schunck, F. C. Luft, and M. Gollasch
Vascular: The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK {alpha} channel subunit in rodents
Exp Physiol, November 1, 2007; 92(6): 1067 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier
Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. N. Muller, J. Theuer, E. Shagdarsuren, E. Kaergel, H. Honeck, J.-K. Park, M. Markovic, E. Barbosa-Sicard, R. Dechend, M. Wellner, et al.
A Peroxisome Proliferator-Activated Receptor-{alpha} Activator Induces Renal CYP2C23 Activity and Protects from Angiotensin II-Induced Renal Injury
Am. J. Pathol., February 1, 2004; 164(2): 521 - 532.
[Abstract] [Full Text] [PDF]